highly significantp < 0.001
Using ANOVA and the post hoc Tukey analysis, the difference between active formulation and placebo was highly significant ( p < 0.001).
Using ANOVA and the post hoc Tukey analysis, the difference between active formulation and placebo was highly significant ( p < 0.001).
The Edelweiss group displayed a strong trend towards an increased anagen‐to‐catagen/telogen ratio compared with the placebo group ( p = 0.07), which was normalized to 1 (Figure 4c ).